DXCM DEXCOM INC

Ownership history in Riverstone Advisors, LLC  ·  22 quarters on record

This page tracks every 13F SEC filing in which Riverstone Advisors, LLC reported a position in DEXCOM INC (DXCM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.0% (2023 Q2)
Avg. % of fund
2.4%
First filed
2020 Q2
Last filed
2025 Q3
Quarters held
22
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 4,815 -3,379 -41.2% 0.16% $324K $67.29
2025 Q2 REDUCED 8,194 -2,650 -24.4% 0.39% $715K $87.29
2025 Q1 REDUCED 10,844 -5,721 -34.5% 0.45% $741K $68.29
2024 Q4 REDUCED 16,565 -2,687 -14.0% 0.73% $1.3M $77.77
2024 Q3 REDUCED 19,252 -2,566 -11.8% 0.75% $1.3M $67.04
2024 Q2 REDUCED 21,818 -23,160 -51.5% 1.52% $2.5M $113.38
2024 Q1 REDUCED 44,978 -2,260 -4.8% 3.72% $6.2M $138.70
2023 Q4 REDUCED 47,238 -3,032 -6.0% 3.79% $5.9M $124.09
2023 Q3 REDUCED 50,270 -976 -1.9% 3.24% $4.7M $93.30
2023 Q2 REDUCED 51,246 -766 -1.5% 4.00% $6.6M $128.51
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DXCM price (monthly, adj. close)
← Back to Riverstone Advisors, LLC Holdings